Position in REPL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$671,211
-$196,891 QoQ
Shares Held
87,740
-1.8% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. REPL ranks #139 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in REPL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $671,211 | 87,740 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $868,102 | 89,311 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $416,129 | 99,315 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $947,626 | 102,005 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $930,042 | 95,389 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,156,081 | 95,465 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $966,102 | 88,148 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $764,307 | 84,923 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $646,990 | 79,191 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $650,500 | 77,165 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,207,007 | 70,544 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,616,228 | 69,605 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,296,826 | 73,433 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,704,433 | 62,663 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,018,550 | 58,978 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $769,242 | 44,007 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $554,278 | 32,643 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $840,831 | 31,027 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $908,732 | 30,659 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,093,164 | 28,453 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $720,585 | 23,618 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $944,326 | 24,753 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $445,759 | 19,364 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $507,735 | 20,432 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $153,767 | 15,423 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||